DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Fizazi K, Carducci M, Smith M. et al.
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study.
Lancet 2011;
377: 813-822
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.